These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 27872072

  • 1. Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal Infections.
    Brüggemann RJ, Middel-Baars V, de Lange DW, Colbers A, Girbes AR, Pickkers P, Swart EL.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872072
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM, van der Elst KC, Veringa A, Jongedijk EM, Brüggemann RJ, Koster RA, Kampinga GA, Kosterink JG, van der Werf TS, Zijlstra JG, Touw DJ, Alffenaar JWC.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis.
    Liu P, Ruhnke M, Meersseman W, Paiva JA, Kantecki M, Damle B.
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1672-6. PubMed ID: 23335738
    [Abstract] [Full Text] [Related]

  • 4. Low Caspofungin Exposure in Patients in Intensive Care Units.
    van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855112
    [Abstract] [Full Text] [Related]

  • 5. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
    Lempers VJ, Schouten JA, Hunfeld NG, Colbers A, van Leeuwen HJ, Burger DM, Verweij PE, Pickkers P, Brüggemann RJ.
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4403-9. PubMed ID: 25963988
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis.
    Liu X, Liu D, Pan Y, Li Y.
    J Clin Pharm Ther; 2020 Dec; 45(6):1207-1217. PubMed ID: 32672361
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients.
    Sime FB, Stuart J, Butler J, Starr T, Wallis SC, Pandey S, Lipman J, Roberts JA.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581122
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of caspofungin in ICU patients.
    Muilwijk EW, Schouten JA, van Leeuwen HJ, van Zanten AR, de Lange DW, Colbers A, Verweij PE, Burger DM, Pickkers P, Brüggemann RJ.
    J Antimicrob Chemother; 2014 Dec; 69(12):3294-9. PubMed ID: 25139840
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.
    Dupont H, Massias L, Jung B, Ammenouche N, Montravers P.
    J Antimicrob Chemother; 2017 May 01; 72(5):1429-1432. PubMed ID: 28088767
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.
    Sinnollareddy MG, Roberts JA, Lipman J, Akova M, Bassetti M, De Waele JJ, Kaukonen KM, Koulenti D, Martin C, Montravers P, Rello J, Rhodes A, Starr T, Wallis SC, Dimopoulos G, DALI Study authors.
    Crit Care; 2015 Feb 04; 19(1):33. PubMed ID: 25888060
    [Abstract] [Full Text] [Related]

  • 11. Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.
    Würthwein G, Cornely OA, Trame MN, Vehreschild JJ, Vehreschild MJ, Farowski F, Müller C, Boos J, Hempel G, Hallek M, Groll AH.
    Antimicrob Agents Chemother; 2013 Apr 04; 57(4):1664-71. PubMed ID: 23335740
    [Abstract] [Full Text] [Related]

  • 12. Low but sufficient anidulafungin exposure in critically ill patients.
    van Wanrooy MJ, Rodgers MG, Uges DR, Arends JP, Zijlstra JG, van der Werf TS, Kosterink JG, Alffenaar JW.
    Antimicrob Agents Chemother; 2014 Apr 04; 58(1):304-8. PubMed ID: 24165173
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
    Leitner JM, Meyer B, Fuhrmann V, Saria K, Zuba C, Jäger W, Böhmdorfer M, Thalhammer F.
    J Antimicrob Chemother; 2011 Apr 04; 66(4):880-4. PubMed ID: 21393208
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance.
    Gioia F, Gomez-Lopez A, Alvarez ME, Gomez-García de la Pedrosa E, Martín-Davila P, Cuenca-Estrella M, Moreno S, Fortun J.
    Int J Infect Dis; 2020 Dec 04; 101():24-28. PubMed ID: 32937195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.